브로마디올론 시장 : 예측(2026-2031년)

The global bromadiolone market, with a 4.95% CAGR, is projected to increase from USD 674.128 million in 2025 to USD 900.663 million in 2031.

The bromadiolone market is positioned for growth, driven by its established role as a potent anticoagulant rodenticide. Its primary mechanism, which involves accumulation in the liver of target animals and the disruption of blood coagulation, makes it a major agent for controlling rats and mice. The inclusion of bromadiolone in numerous registered pesticide products underscores its widespread acceptance and utility in both agricultural and urban settings.

A primary driver for market expansion is the increasing prevalence and serious threat of rodent-borne infections. Rodents are vectors for a range of diseases with significant public health implications, including hantavirus, Lassa fever, and leptospirosis. The high fatality rates associated with some of these diseases, coupled with the absence of specific treatments for certain viruses, necessitates effective control measures. This public health imperative is a powerful factor propelling the demand for potent rodenticides like bromadiolone to mitigate infection risks in environments ranging from farms to fields.

The agricultural sector represents a critical and growing end-market. With rising global food demand, farmers are under pressure to enhance crop yields and protect food quality. Rodenticides containing bromadiolone are increasingly adopted as a key tool for crop protection, minimizing pre- and post-harvest losses. This strategic use to safeguard agricultural output and ensure food security demonstrates the compound's significant potential within the industry.

Furthermore, regulatory and governmental bodies play a consequential role in shaping the market. Recognizing the necessity of rodent control, governments have at times provided financial support packages to combat severe rodent infestations, effectively underlining the value of effective control solutions during emergency situations. Concurrently, the establishment of guidelines for the use of bromadiolone-based products reflects a regulatory focus on managing risks, particularly to non-target species, which influences product deployment and application standards.

The intrinsic efficacy of bromadiolone is a fundamental market driver. As a second-generation anticoagulant, it is known for its high potency, often requiring only a single ingestion to be lethal to target rodents. Its stability and formulation versatility-available in paraffinized pellets, meal baits, and ready-to-use packs-enhance its practicality and effectiveness in diverse field conditions, sustaining its demand.

Significant opportunities for market development exist in the expansion of usage within urban and commercial settings, where awareness of rodent-related health issues is growing. Additionally, a clear market opportunity is emerging for the development of more eco-friendly or targeted rodenticide solutions. This focus area presents a potential avenue for new entrants and established players to innovate and capture market share by addressing environmental concerns.

Geographically, the Asia-Pacific region is expected to be the dominant market for bromadiolone. This leadership is attributed to the region's large agricultural base and the presence of numerous local manufacturers specializing in rodent control products. The combination of a significant rodent population and a strong foundational industry positions the region for substantial market growth.

The competitive landscape includes established international players such as Syngenta and BASF, which offer high-efficacy bromadiolone-based products like Klerat Waxblocks and Storm(R) Secure. These companies, along with specialized firms like PelGar International, leverage their expertise in pest control to provide targeted solutions, underscoring a market that is responsive to the need for effective and reliable rodent management strategies.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2021 to 2025 & forecast data from 2026 to 2031
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information), and Key Developments among others.

Bromadiolone Market Segmentation:

• By Pest Type
• Rats & Mice
• Voles
• By Product Type
• Powder
• Pellets & Bait Blocks
• Liquid
• By End-User
• Residential
• Industrial & Commercial
• By Geography
• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• France
• United Kingdom
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Israel
• Others
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Thailand
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL BROMADIOLONE MARKET BY PEST TYPE

• 5.1. Introduction
• 5.2. Rats & Mice
• 5.3. Voles

6. GLOBAL BROMADIOLONE MARKET BY PRODUCT TYPE

• 6.1. Introduction
• 6.2. Powder
• 6.3. Pellets & Bait Blocks
• 6.4. Liquid

7. GLOBAL BROMADIOLONE MARKET BY END-USER

• 7.1. Introduction
• 7.2. Residential
• 7.3. Industrial & Commercial

8. GLOBAL BROMADIOLONE MARKET BY GEOGRAPHY

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. USA
  • 8.2.2. Canada
  • 8.2.3. Mexico
• 8.3. South America
  • 8.3.1. Brazil
  • 8.3.2. Argentina
  • 8.3.3. Others
• 8.4. Europe
  • 8.4.1. Germany
  • 8.4.2. France
  • 8.4.3. United Kingdom
  • 8.4.4. Spain
  • 8.4.5. Others
• 8.5. Middle East and Africa
  • 8.5.1. Saudi Arabia
  • 8.5.2. UAE
  • 8.5.3. Israel
  • 8.5.4. Others
• 8.6. Asia Pacific
  • 8.6.1. China
  • 8.6.2. India
  • 8.6.3. Japan
  • 8.6.4. South Korea
  • 8.6.5. Indonesia
  • 8.6.6. Thailand
  • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 9.1. Major Players and Strategy Analysis
• 9.2. Market Share Analysis
• 9.3. Mergers, Acquisitions, Agreements, and Collaborations
• 9.4. Competitive Dashboard

10. COMPANY PROFILES

• 10.1. PelGar International
• 10.2. Bayer AG
• 10.3. Liphatech Inc.
• 10.4. BASF SE
• 10.5. Syngenta Group
• 10.6. Bell Laboratories Inc.
• 10.7. JT Eaton & Co., Inc.
• 10.8. Kalyani Industries Limited
• 10.9. HPC Standards GmbH
• 10.10. HEBEI ENGE BIOTECH CO., LTD

11. APPENDIX

• 11.1. Currency
• 11.2. Assumptions
• 11.3. Base and Forecast Years Timeline
• 11.4. Key Benefits for the Stakeholders
• 11.5. Research Methodology
• 11.6. Abbreviations